Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IGC Pharma (IGC) Return on Capital Employed (2016 - 2025)

IGC Pharma (IGC) has disclosed Return on Capital Employed for 15 consecutive years, with 1.1% as the latest value for Q3 2025.

  • Quarterly Return on Capital Employed fell 81.0% to 1.1% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 1.1% through Sep 2025, down 81.0% year-over-year, with the annual reading at 1.05% for FY2025, 81.0% down from the prior year.
  • Return on Capital Employed for Q3 2025 was 1.1% at IGC Pharma, down from 1.05% in the prior quarter.
  • The five-year high for Return on Capital Employed was 0.09% in Q3 2022, with the low at 1.12% in Q1 2025.
  • Average Return on Capital Employed over 5 years is 0.5%, with a median of 0.36% recorded in 2021.
  • The sharpest move saw Return on Capital Employed tumbled -89bps in 2023, then skyrocketed 82bps in 2024.
  • Over 5 years, Return on Capital Employed stood at 0.37% in 2021, then soared by 76bps to 0.09% in 2022, then tumbled by -970bps to 0.98% in 2023, then surged by 84bps to 0.16% in 2024, then tumbled by -587bps to 1.1% in 2025.
  • According to Business Quant data, Return on Capital Employed over the past three periods came in at 1.1%, 1.05%, and 1.12% for Q3 2025, Q2 2025, and Q1 2025 respectively.